PTC
REPL icon

Private Trust Company’s Replimune Group REPL Stock Holding History

Private Trust Company’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-83
Closed -$678 – 2338
2024
Q1 		$678 Hold
83
– – ﹤0.01% 2174
2023
Q4 		$700 Buy
+83
New +$962 ﹤0.01% 2219

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Private Trust Company's REPL Position: Q2 2024 in Review

Private Trust Company sold out of Replimune Group (REPL) in Q2 2024, closing a stake of 83 shares — an estimated $678 sold.

Private Trust Company first reported a position in REPL in Q4 2023 and held it in 2 quarters. The position peaked at $700 in Q4 2023. 149 funds tracked by Wall St. Rank hold REPL as of Q2 2024.

  • Private Trust Company reported no remaining Replimune Group position as of Q2 2024 after selling out during the quarter.
  • Private Trust Company sold 83 Replimune Group shares in Q2 2024, an estimated $678.
  • Private Trust Company first reported a position in Replimune Group in Q4 2023 and held it in 2 quarters.
  • Private Trust Company's Replimune Group position peaked at $700 in Q4 2023.
  • 149 funds tracked by Wall St. Rank held Replimune Group as of Q2 2024.

Based on Private Trust Company's 13F filing for Q2 2024, filed 23 Jul 2024.